Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer

SY Park, J Jun, KJ Jeong, HJ Heo… - Oncology …, 2011 - spandidos-publications.com
SY Park, J Jun, KJ Jeong, HJ Heo, JS Sohn, HY Lee, CG Park, J Kang
Oncology reports, 2011spandidos-publications.com
Histone deacetylases (HDACs) are associated with the development and progression of
cancer, but it is not known which of the HDAC isoforms play important roles in breast cancer
metastasis. This study identified the specific HDAC isoforms that are necessary for invasion
and/or migration in human breast cancer cell lines. MDA-MB-231 cells were significantly
more invasive and expressed higher levels of matrix metalloproteinase-9 (MMP-9)
compared to MCF-7 cells. We compared the expression of HDAC isoforms between MCF-7 …
Abstract
Histone deacetylases (HDACs) are associated with the development and progression of cancer, but it is not known which of the HDAC isoforms play important roles in breast cancer metastasis. This study identified the specific HDAC isoforms that are necessary for invasion and/or migration in human breast cancer cell lines. MDA-MB-231 cells were significantly more invasive and expressed higher levels of matrix metalloproteinase-9 (MMP-9) compared to MCF-7 cells. We compared the expression of HDAC isoforms between MCF-7 and MDA-MB-231 cells and found greater expression of HDAC4, 6 and 8 in MDA-MB-231 cells by RT-PCR and Western blot analyses. In addition, apicidin, a histone deacetylase inhibitor, was shown to attenuate the invasion, migration and MMP-9 expression in MDA-MB-231 cells. Using specific siRNAs directed against HDAC1, 4, 6 and 8, we show that inhibition of HDAC1, 6 and 8, but not HDAC4, are responsible for invasion and MMP-9 expression in MDA-MB-231 cells. We analyzed the invasiveness of MCF-7 cells overexpressing HDAC1, 4, 6 or 8 and found that overexpression of HDAC1, 6 or 8 increased invasion and MMP-9 expression. By developing HDAC isoforms as potential biomarkers for breast cancer metastasis, the present study can be extended to developing therapies for breast cancer invasion.
Spandidos Publications